In human cancer cells, we identified an N-terminally deleted form of AFXα (α198-505), translated from a downstream start and 2 short N-terminal AFX proteins (90, and 101 a.a.)produced by aberrant splicing. This evidence concerns the gene FOXO4 and cancer.